Startup profile · funding coverage
Maven funding, valuation and investors
Virtual clinic for women's and family health — fertility, maternity, pediatrics, and menopause.
Keep track of Maven
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series F
$125M · October 2024
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$125M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · New York, New York
Investors in latest funding
Other: Sequoia , General Catalyst , Lux Capital , Andreessen Horowitz
Overview
Maven Clinic is a virtual healthcare platform specializing in women's and family health, including fertility, pregnancy, pediatrics, and menopause care. Employers offer Maven as a benefit connecting members with providers via video and messaging. Founded by Kate Ryder, Maven raised a $125M Series F in October 2024 with Sequoia, General Catalyst, Lux Capital, and Andreessen Horowitz among participants, bringing total funding above $425M.
Why Maven is interesting
Maven became the largest virtual women's-health clinic with $425M+ raised — a16z joined a cap table including Sequoia and General Catalyst as employers adopted Maven as family-benefits infrastructure.
Product & use cases
Maven provides employer-sponsored virtual care across the family health journey: fertility consultations, maternity coaching, pediatric support, and menopause management — with dedicated care advocates and provider networks.
- Employers offering fertility and maternity benefits to improve retention and reduce healthcare costs
- Members accessing OB-GYNs, fertility specialists, and lactation consultants via app
- HR teams reporting on family-health benefit utilization and outcomes
Key facts
- Series F (Oct 2024): $125M; total funding $425M+ (PR Newswire)
- Largest virtual clinic focused on women's and family health
- Employer benefits platform covering fertility through menopause
- Founded 2014 by Kate Ryder
Funding history (newest first)
Series F
2024-10 $125M- Sequoia (participant)
- General Catalyst (participant)
- Lux Capital (participant)
- Andreessen Horowitz (participant)
Source: Read source · prnewswire.com
Investors in our directory
Funds linked from Maven's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Maven built the category-defining employer benefit for women's health before incumbents reacted — network depth across fertility-to-pediatrics creates switching costs for enterprise buyers.
Employer-sponsored women's health went from perk to retention necessity. Maven's scale ($425M+ raised) reflects category leadership but incumbents and point-solution fertility vendors keep enterprise RFPs competitive.
-
Teladoc / major telehealth incumbent
General telehealth adding women's health modules; Maven's specialized vertical depth.
-
Progyny adjacent
Fertility benefits manager; narrower focus vs Maven's full family health span.
-
Carrot Fertility direct
Employer fertility benefits competitor; overlaps on fertility but less maternity/pediatrics breadth.
Notable stories
- Kate Ryder founded Maven after seeing friends struggle to navigate fertility and maternity care — building employer benefits before 'women's health' was standard in corporate wellness packages.
- Maven's Series F during 2024 reflected continued employer demand for family benefits despite broader digital health funding slowdown.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Maven's financing or category context.
FAQs about Maven
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.